Guest guest Posted February 22, 2011 Report Share Posted February 22, 2011 Liver InternationalLiver International © Wiley & Sons A/S Early View (Articles online in advance of print) Clinical Studies Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study Marcellin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel Rotily, Marina Varastet, Jean-Philippe Lang, Pascal Melin and Patrice Cacoub, for the CheObs Study Group Article first published online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02461.x Corrigendum CORRIGENDUM Article first published online: 17 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02492.x This article corrects: Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis Vol. 31, Issue 3, 401–411, Article first published online: 11 JAN 2011 These Early View articles are now available on Wiley Online Library Basic Studies A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice Masaaki Korenaga, Isao Hidaka, Sohji Nishina, Aya Sakai, Akane Shinozaki, Toshikazu Gondo, Takakazu Furutani, Hiroo Kawano, Isao Sakaida and Keisuke Hino Article first published online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02469.x Quote Link to comment Share on other sites More sharing options...
Guest guest Posted February 22, 2011 Report Share Posted February 22, 2011 Liver InternationalLiver International © Wiley & Sons A/S Early View (Articles online in advance of print) Clinical Studies Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study Marcellin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel Rotily, Marina Varastet, Jean-Philippe Lang, Pascal Melin and Patrice Cacoub, for the CheObs Study Group Article first published online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02461.x Corrigendum CORRIGENDUM Article first published online: 17 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02492.x This article corrects: Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis Vol. 31, Issue 3, 401–411, Article first published online: 11 JAN 2011 These Early View articles are now available on Wiley Online Library Basic Studies A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice Masaaki Korenaga, Isao Hidaka, Sohji Nishina, Aya Sakai, Akane Shinozaki, Toshikazu Gondo, Takakazu Furutani, Hiroo Kawano, Isao Sakaida and Keisuke Hino Article first published online: 15 FEB 2011 | DOI: 10.1111/j.1478-3231.2011.02469.x Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.